Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 09-1995 | 06-1995 | 03-1995 | 12-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 115,150 | 155,043 | 180,525 | 191,169 | 90,077 |
| Marketable Securities | 35,624 | 6,516 | 36,596 | 34,045 | 28,279 |
| Receivables | 209,535 | 146,877 | 145,337 | 137,605 | 74,770 |
| Inventories | 144,615 | 104,933 | 96,426 | 85,897 | 54,673 |
| Other current assets | 32,133 | 46,379 | 71,844 | 73,097 | 15,986 |
| TOTAL | $537,057 | $459,748 | $530,728 | $521,813 | $263,785 |
| Non-Current Assets | |||||
| PPE Net | 365,031 | N/A | N/A | N/A | 142,984 |
| Investments And Advances | 67,988 | 0 | 0 | 0 | 19,470 |
| Other Non-Current Assets | 216,460 | 174,047 | 167,980 | 170,782 | 35,337 |
| TOTAL | $649,479 | $174,047 | $167,980 | $170,782 | $197,791 |
| Total Assets | $1,075,273 | $831,131 | $890,778 | $871,053 | $431,841 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 28,568 | 54,802 | 66,223 | 34,249 |
| Accounts payable and accrued liabilities | 42,240 | 81,381 | 71,168 | 79,816 | 15,109 |
| Accrued Expenses | 141,030 | 22,245 | 110,958 | 116,147 | 14,843 |
| Other current liabilities | 13,625 | 2,547 | 5,534 | 5,159 | 3,879 |
| TOTAL | $270,481 | $138,682 | $254,439 | $291,448 | $73,681 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,162 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 39,058 | 29,039 | 29,685 | 30,917 | 3,021 |
| TOTAL | $52,260 | $49,882 | $51,053 | $52,337 | $18,151 |
| Total Liabilities | $322,741 | $188,564 | $305,492 | $343,785 | $91,832 |
| Shareholders' Equity | |||||
| Common Shares | 1,757 | 1,545 | 1,545 | 1,545 | 1,018 |
| Retained earnings | 455,545 | 468,770 | 421,730 | 375,808 | 253,953 |
| Other shareholders' equity | -8,685 | -9,426 | -6,427 | -3,028 | -112 |
| TOTAL | $752,532 | $642,567 | $585,286 | $527,268 | $340,009 |
| Total Liabilities And Equity | $1,075,273 | $831,131 | $890,778 | $871,053 | $431,841 |